Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatmentMackenzie Bender(Yale University), Marlies Meisel(UPMC Hillman Cancer Center)CellApril 1, 202310.1016/j.cell.2023.03.011Cited by 635SaveCiteExport RISWatch citationsRelated PapersReovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease|Science|2017|453Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host|Nature|2018|405Melanoma and microbiota: Current understanding and future directions|Cancer Cell|2023|78Dietary tryptophan catabolite released by intratumoral Lactobacillus reuteri facilitates αPD-L1 therapy|Research Square|2022|1